发明名称 |
ATTENUATED DENGUE VIRUS VACCINE CONTAINING ADAPTIVE MUTATION FROM MRC-5 CELLS |
摘要 |
The present invention relates to an attenuated dengue virus vaccine. In present invention, target mutagenesis at Glu345Lys was constructed in two infectious cDNA clones of a recombinant version of wild type virus DEN-4 2A and its derived 3′ NCR deletion mutant vaccine candidate virus DEN-4 2A&Dgr;30. Using PCR-mediated site-directed mutagenesis method, the infectious cDNA clone-derived Glu345-Lys mutants of DEN-4 2A and DEN-4 2A&Dgr;30 were passaged in Vero cells and MRC-5 cells for five consecutive times. The results shows that single point mutation E-Glu345Lys of DEN-4 2A and DEN-4 2A&Dgr;30 were found stably existed when passaged in MRC-5 cells, which means mutagenesis at Glu345Lys of DEN-4 2A and DEN-4 2A&Dgr;30 are both suitable to be probagated in MRC-5 cell for producing virulence attenuated dengue virus vaccine.
|
申请公布号 |
US2012269853(A1) |
申请公布日期 |
2012.10.25 |
申请号 |
US201113090627 |
申请日期 |
2011.04.20 |
申请人 |
WU SUH-CHIN;LEE HSIANG-CHI;HSIAO HUNG-JU;LIN HSIAO-HAN;NATIONAL TSING HUA UNIVERSITY |
发明人 |
WU SUH-CHIN;LEE HSIANG-CHI;HSIAO HUNG-JU;LIN HSIAO-HAN |
分类号 |
A61K39/12;A61P31/14 |
主分类号 |
A61K39/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|